You are here

Home > News > All Press Releases

Press Releases

Prof. Haim Harari

Weizmann Institute President Appointed Special Advisor to Madame Edith Cresson

06.03.1997
REHOVOT, Israel -- March 6, 1997 -- Mme Edith Cresson, former Prime Minister of France and currently a member of the European Commission with responsibility for science, research and technological development, has just announced the appointment of Weizmann Institute of Science President Prof. Haim Harari as her special advisor. The appointment covers the fields of science education and international scientific cooperation.  
New Method for the Separation of Isotopes

New Method for the Separation of Isotopes

23.02.1997
First Practical Application of a Textbook Concept Bridging the Gap Between Classical and Quantum Physics REHOVOT, Israel -- February 23, 1997 -- A Weizmann Institute of Science researcher has turned a 70-year-old textbook concept in quantum mechanics into a practical method for separating isotopes, different "versions" of the same element.
Key Step in Activating Immune System Discovered

Key Step in Activating Immune System Discovered

06.02.1997
Disease, Drugs & Diagnostics
REHOVOT, Israel - February 6, 1997 - A gene that plays a key role in activating the immune system -- and perhaps also in spurring on the human immunodeficiency virus that causes AIDS -- has been discovered and cloned by researchers at the Weizmann Institute of Science. Their findings will be reported in the February 6, 1997, issue of Nature.  
Pacman in the Brain: Protein Chews up Vital Memory Chemical

Pacman in the Brain: Protein Chews up Vital Memory Chemical

01.02.1997
Brain & Behavior
What does the human brain have in common with a popular video game and a carnivorous flower? At least one thing, it turns out. A team from Israel's Weizmann Institute of Science and France's Pasteur Institute found that proteins called glutamate receptors, which enable brain cells to absorb glutamate, a chemical vital for memory and learning, are strikingly similar in shape to both Pacman and the Venus flytrap.  
The Watery Birth of Stars

The Watery Birth of Stars

01.02.1997
Logically, stars should not exist. They are born when clouds of interstellar gas collapse inwardly under their own weight, growing denser and hotter until nuclear fusion causes them to emit energy in the form of light. However, since heat forces matter to expand, this hot contracting gas could be expected to immediately move outward again, preventing star formation from ever reaching completion.
Prof. Ruth Arnon

'Women of Distinction' Award to Two Weizmann Institute Scientists

28.01.1997
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an achievement that bears on the lives of many people throughout the world. Prof. Ruth Arnon and Dr. Dvora Teitelbaum received Women of Distinction Awards from Hadassah, the Women's Zionist Organization of America, for three decades of pioneering scientific research that led to a new drug for multiple sclerosis.  
On the Surface of Things

On the Surface of Things

02.01.1997
Materials Science
From pens to pans, from hard disks to compact discs, an increasing number of products are made of polymers, giant complex molecules with repeating structural units. Different polymers are often mixed together in liquid form and then allowed to harden in order to impart the best properties of each to the final product. During the mixing, certain types of polymers are more likely than others to move to the surface, forming a coating that thickens with time.
Study Shows How Ancient Chinese Herb May Act As Alzheimer Drug

Study Shows How Ancient Chinese Herb May Act As Alzheimer Drug

01.01.1997
REHOVOT, Israel -- January 1, 1997 -- A new Weizmann Institute study shows exactly how a substance derived from a moss long used in Chinese folk medicine blocks a brain enzyme that may be involved in Alzheimer disease.
New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996
Disease, Drugs & Diagnostics
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli drug copolymer-1, to be marketed under the brand name COPAXONE, for treatment of patients with relapsing-remitting multiple sclerosis.
Potential Weight-Loss Drug May Be Linked to Adult Diabetes

Potential Weight-Loss Drug May Be Linked to Adult Diabetes

15.11.1996
Disease, Drugs & Diagnostics
REHOVOT, Israel -- November 15, 1996 -- Leptin, the protein that made headlines two years ago when it was found to reduce obesity in mice, may be a cause of adult-onset diabetes in humans, according to a new Weizmann Institute of Science study.  

Pages

 

Are you a journalist? Please sign up here for our press releases

 

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research